Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

RCT BioVentures

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 4
Average round size
info
The average size of a deal this fund participated in
$11M
Portfolio companies 3
Rounds per year 0.12
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.25
Exits 1
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Pharmaceutical
  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
Summary

RCT BioVentures is the famous VC, which was founded in 1987. The leading representative office of defined VC is situated in the Tucson. The fund was located in North America if to be more exact in United States. RCT BioVentures seemed to be an CVC arrangement as part of the organization.

For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has no exact preference in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Catalyst Biosciences, Cylene Pharmaceuticals. Among the most successful fund investment fields, there are Pharmaceutical, Health Care.

The standard case for the fund is to invest in rounds with 4 partakers. Despite the RCT BioVentures, startups are often financed by Sofinnova Investments, Oxford Bioscience Partners, Jafco Life Science. The meaningful sponsors for the fund in investment in the same round are Sofinnova Investments, Novartis Venture Fund, Sanderling Ventures. In the next rounds fund is usually obtained by Sofinnova Investments, Novartis Venture Fund, Morgenthaler Ventures.

The top activity for fund was in 2006. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The increased amount of exits for fund were in 2006. This RCT BioVentures works on 4 percentage points more the average amount of lead investments comparing to the other organizations.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of RCT BioVentures:
Typical Co-investors
RCT BioVentures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after RCT BioVentures:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Applifting -
Big Issue Invest England, London, United Kingdom
Chengdu Honghe Investment Chengdu, China, Sichuan
MMIC Investment Holdings -
NPR Holdings -
Royal Dutch Shell The Hague, The Netherlands, Zuid-Holland
SDC Capital Partners New York, New York, United States
Spectralmind Austria, Vienna
Yichengdachang Chengdu, China, Sichuan

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Catalyst Biosciences

Biotechnology
Health Care
Life Science
Medical
Medical Device
Pharmaceutical
Therapeutics
$30M09 Feb 2006 South San Francisco, California, United States

Imagine Pharmaceuticals

Pharmaceutical
$3M27 Apr 2004 Easttown Township, Pennsylvania, United States

Catalyst Biosciences

Biotechnology
Health Care
Life Science
Medical
Medical Device
Pharmaceutical
Therapeutics
$10M17 Nov 2003 South San Francisco, California, United States

Cylene Pharmaceuticals

Biotechnology
Health Care
Pharmaceutical
$3M17 Oct 2001 San Diego, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent RCT BioVentures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 4
Average round size 11M
Rounds per year 0.12
Peak activity year 2003
Lead investments 0
Follow on index 0.25
Exits 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Catalyst Biosciences

Biotechnology
Health Care
Life Science
Medical
Medical Device
Pharmaceutical
Therapeutics
$30M09 Feb 2006 South San Francisco, California, United States

Imagine Pharmaceuticals

Pharmaceutical
$3M27 Apr 2004 Easttown Township, Pennsylvania, United States

Catalyst Biosciences

Biotechnology
Health Care
Life Science
Medical
Medical Device
Pharmaceutical
Therapeutics
$10M17 Nov 2003 South San Francisco, California, United States

Cylene Pharmaceuticals

Biotechnology
Health Care
Pharmaceutical
$3M17 Oct 2001 San Diego, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: